PMP2
Myelin P2 protein
Also known as: FABP8, M-FABP, MP2, MYP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P02689
- Gene
- PMP2
- Ensembl
- ENSG00000147588
- Chromosome
- 8
- Canonical length
- 132 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene localizes to myelin sheaths of the peripheral nervous system. The encoded protein can bind both the membrane layers of the sheaths and monomeric lipids, and is thought to provide stability to the sheath. A defect in this gene was shown to be a cause of dominant demyelinating CMT neuropathy. [provided by RefSeq, Jan 2017]
Canonical amino-acid sequenceUniProt
132 residues, UniProt reviewed canonical sequence.
>P02689|PMP2
1 MSNKFLGTWK LVSSENFDDY MKALGVGLAT RKLGNLAKPT VIISKKGDII TIRTESTFKN
61 TEISFKLGQE FEETTADNRK TKSIVTLQRG SLNQVQRWDG KETTIKRKLV NGKMVAECKM
121 KGVVCTRIYE KVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PMP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 389 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 389 nTPM
- midbrain: 290 nTPM
- amygdala: 199 nTPM
- hypothalamus: 184 nTPM
- basal ganglia: 171 nTPM
- cerebral cortex: 163 nTPM
Single-cell type
- schwann cells: 161 nCPM
- astrocytes: 117 nCPM
- oligodendrocyte progenitor cells: 106 nCPM
- oligodendrocytes: 80 nCPM
- müller glia: 64 nCPM
- bergmann glia: 39 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 423 nTPM
- white matter: 403 nTPM
- spinal cord: 357 nTPM
- midbrain: 347 nTPM
- cerebellum: 318 nTPM
- pons: 299 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PMP2.
Disease | AllUniProt
Conditions PMP2 is implicated in, by any mechanism.
- Charcot-Marie-Tooth disease, demyelinating, type 1G (CMT1G) MIM:618279
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 135 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Charcot-Marie-Tooth disease, demyelinating, type 1G
- Peripheral neuropathy
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.1
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PMP2 as an antibody target. Whether an autoantibody or antibody against PMP2 could matter depends on whether native PMP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PMP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PMP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...